Pure Global

Feasibility Study of ABC for Women Treated for Breast Cancer - Trial NCT06412341

Access comprehensive clinical trial information for NCT06412341 through Pure Global AI's free database. This phase not specified trial is sponsored by University of the West of England and is currently Not yet recruiting. The study focuses on Breast Cancer Female. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06412341
Not yet recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06412341
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Feasibility Study of ABC for Women Treated for Breast Cancer
A Feasibility Study to Inform an RCT to Evaluate 'Accepting Your Body After Cancer', an Online-delivered, Group-based CBT Body Image Intervention, for Women Who Have Received Treatment for Breast Cancer

Study Focus

Breast Cancer Female

Accepting your Body after Cancer

Interventional

behavioral

Sponsor & Location

University of the West of England

Bristol, United Kingdom

Timeline & Enrollment

N/A

May 05, 2024

Mar 31, 2026

120 participants

Primary Outcome

Recruitment rates,Response rates - Self-report outcome measures,Response rates - Intervention arm,Response rates - Control arm,Quantitative assessment of acceptability - ABC,Quantitative assessment of acceptability - Research process,Qualitative assessment of acceptability - ABC (Open-ended questions),Qualitative assessment of acceptability - ABC (interviews,Qualitative assessment of acceptability - Research process (Open-ended questions),Qualitative assessment of acceptability - Research process (interviews),Qualitative assessment of acceptability - ABC course facilitators

Summary

The investigators aim to assess the feasibility and acceptability of conducting a randomised
 controlled trial (RCT) to test whether receiving ABC (an online-delivered, Cognitive
 Behavioural Therapy [CBT], group-based, body image programme) alongside a psychoeducational
 body image booklet provides greater benefits to women treated for breast cancer compared to a
 receiving a psychoeducational body image booklet alone.
 
 Results from this feasibility study will inform the design, management, and future delivery
 of a definitive randomised controlled trial to assess effectiveness and cost-effectiveness of
 ABC.
 
 Specific objectives are to:
 
 - Establish appropriate, inclusive, and acceptable methods of participant recruitment,
 retention, and management procedures.
 
 - Establish the feasibility and acceptability of quantitative data collection, including
 determining appropriate primary and secondary outcome measures.
 
 - Adapt and test a measure of health and social care service use, to inform a future
 economic evaluation.
 
 - Establish intervention adherence and acceptability (of online setting) among
 participants and ABC facilitators.
 
 Participants will be randomised to either the intervention or control arm. The control arm
 will receive the Macmillan Cancer Support psychoeducational body image booklet. The
 intervention arm will receive the Macmillan booklet and the ABC programme, a 7-session, CBT
 group-based programme delivered online. All participants will complete self-report validated
 outcome measures at weeks 1 (T1; baseline/pre-intervention), 9 (T2; immediate
 post-intervention), 20 (T3; three-month post intervention), and 32 (T4; six-month post
 intervention). Following drop-out or completion of all study procedures, a subset of
 participants will be invited to take part in interviews.

ICD-10 Classifications

Malignant neoplasm: Breast, unspecified
Malignant neoplasm of breast
Malignant neoplasm of breast
Carcinoma in situ of breast, unspecified
Personal history of malignant neoplasm of breast

Data Source

ClinicalTrials.gov

NCT06412341

Non-Device Trial